株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

CRISPR技術の世界市場:成長、動向、および予測(2019年~2024年)

CRISPR Technology Market - Growth, Trends, and Forecast (2019 - 2024)

発行 Mordor Intelligence LLP 商品コード 911960
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
CRISPR技術の世界市場:成長、動向、および予測(2019年~2024年) CRISPR Technology Market - Growth, Trends, and Forecast (2019 - 2024)
出版日: 2019年09月01日 ページ情報: 英文 114 Pages
概要

世界のCRISPR技術市場は、2019年から2024年の間に24.3%のCAGRで成長する見通しです。

当レポートは世界のCRISPR技術市場について調査しており、市場機会や動向、成長および阻害要因、製品・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
  • 阻害要因
  • ポーターのファイブフォース分析

第5章 市場セグメント

  • 製品別
  • 用途別
  • エンドユーザー別
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Agilent Technologies
    • Cellecta, Inc.
    • GeneCopoeia, Inc.
    • GenScript
    • Horizon Discovery Group
    • Integrated DNA Technologies (IDT)
    • Merck KGaA
    • New England Biolabs
    • Origene Technologies, Inc.
    • Thermo Fisher Scientific

第7章 市場機会および今後の動向

目次
Product Code: 66771

Market Overview

Global CRISPR Technology market is expected to witness a CAGR of 24.3% during the forecast period. Certain factors that are driving the market growth include increasing government and private funding, rising demand, and adoption of CRISPR, technological advancements.

The rise in funding, initiatives by the government to develop vaccines, medical technologies, drugs, devices are further propelling the growth of the genome editing market globally. For instance, In May 2018, Feng Zhang's company Beam Therapeutics, a new startup to develop CRISPR, officially came out with USD 87 million in series. Funding and a mission to develop "precision genetic medicines" that use CRISPR technology to edit just one nucleotide base, or "letter," in the genome at a time. In 2018, Inscripta Colorado-based biotech acquired Solana Biosciences to ramp up the commercialization of its gene-editing technology. Aiming to broaden access to CRISPR by offering new enzymes for free, and to boost CRISPR research by outfitting scientists with a full suite of tools. Furthermore, in 2017, Synthego and Thermo Fisher Scientific collaborated to manufacture and distribute synthetic guide RNA products for CRISPR genome engineering.

Scope of the Report

CRISPR technology is a straightforward yet commanding tool for the purpose of editing genomes. It enables researchers to alter DNA sequences without difficulty and further modify gene function. It has a number of potential applications which include treating and preventing the spread of diseases, correcting genetic defects, and also, improving crops.

Key Market Trends

Biomedical is Expected to Hold Significant Market Share in the Application Segment

At present, the CRISPR (clustered regularly interspaced short palindromic repeat) restoration system is undeniably considered as one of the most suitable as well as promising options for genome editing. As compared to previous systems, CRISPR has more potentials and applications. Among all these, one important application is the use of CRISPR in understanding various genetic and epigenetic diseases including cancer. Study of cancer by the CRISPR system is mostly done by two approaches i.e. turning on the tumor suppressor genes and turning off the oncogenes. As per the exact capability of CRISPR, this system can also be utilized to create specific mutations in different cell lines in order to model the cancers. This type of modeling can result in a better understanding of a variety of diseases such as cancer and the ability to further develop effective drugs.

North America Dominates the Market and Expected to do Same in the Forecast Period

The region, especially the United States, has always been a pioneer in the field of genome editing, mostly due to the favorable government initiatives and increase in funding. The first-ever US trial of CRISPR in humans has begun in April 2019. Two patients are presently being treated as part of a study being conducted by the University of Pennsylvania. According to NPR (National Public Radio, America), both have certain forms of cancer which are difficult to treat and both have relapsed after standard treatments. As part of the trial, researchers are taking immune cells from the patients' bodies and then are editing them with CRISPR before again putting them back in. Such novel researches are expected to drive the overall market growth throughout the region.

Competitive Landscape

The global CRISPR technology market is highly competitive and consists of a number of major players. Companies like Agilent Technologies, Cellecta, Inc., GeneCopoeia, Inc., GenScript, Horizon Discovery Group, Integrated DNA Technologies (IDT), Merck KGaA, New England Biolabs, Origene Technologies, Inc., Thermo Fisher Scientific, among others, hold the substantial market share in the CRISPR technology market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Government and Private Funding
    • 4.2.2 Rising Demand and Adoption of CRISPR
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Using CRISPR
    • 4.3.2 Ethical Concerns Related to Genetic Research
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Product
    • 5.1.1 Enzymes
    • 5.1.2 Kits & Reagents
    • 5.1.3 Guide RNA
    • 5.1.4 Others (Antibodies, Vectors, Design Tools, etc.)
  • 5.2 Application
    • 5.2.1 Biomedical
    • 5.2.2 Agricultural
    • 5.2.3 Industrial
    • 5.2.4 Others
  • 5.3 End-User
    • 5.3.1 Pharmaceutical companies and Biotechnology Companies
    • 5.3.2 Academics and Government Research Institutes
    • 5.3.3 Others (CROs etc.)
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Cellecta, Inc.
    • 6.1.3 GeneCopoeia, Inc.
    • 6.1.4 GenScript
    • 6.1.5 Horizon Discovery Group
    • 6.1.6 Integrated DNA Technologies (IDT)
    • 6.1.7 Merck KGaA
    • 6.1.8 New England Biolabs
    • 6.1.9 Origene Technologies, Inc.
    • 6.1.10 Thermo Fisher Scientific

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top